DC Chemicals

All products / DC10172

WT-161
CAT. NO. DC10172

WT-161

Pack sizes and prices

Pack sizePrice
100 mg$350 USDRequest a quote / confirm availability →
250 mg$700 USDRequest a quote / confirm availability →
1 g$1,400 USDRequest a quote / confirm availability →
10 mM * 1 mL in DMSO$150 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

WT161 selectively inhibits HDAC6 and dramatically increases levels of acetylated α-tubulin (Ac-α-tubulin) with little effect on global lysine acetylation. WT161 induces significant toxicity in all multiple myeloma cell lines tested, with IC50s between 1.5 and 4.7 µM . WT161 in combination with bortezomib triggers significant accumulation of polyubiquitinated proteins and cell stress, followed by caspase activation and apoptosis. More importantly, this combination treatment is effective in bortezomib-resistant cells and in the presence of bone marrow stromal cells, which have been shown to mediate multiple myeloma cell drug resistance.WT161 shows toxicity at 100 mg/kg i.p., but WT161 is well tolerated at 50 mg/kg i.p.. Bortezomib combined with WT161 demonstrates a significant antitumor effect.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC10172
Product nameWT-161
CAS1206731-57-8
Molecular formulaC27H30N4O3
Molecular weight458.55
Purity>98%
SMILESO=C(CCCCCCC(=O)N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1)NO

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — WT-161 (DC10172)

Related research products

Browse newly added products